Brind.

Pluri Inc. is listed on the Nasdaq exchange and focusing on US commercial activity, while Alejandro Weinstein holds over 30% ownership. Separately, Abbott acquired CFR Pharmaceuticals for $2.9 billion.

2 reports, 2 independent Updated Sep 1
Gone quiet
Reports
2
Developments
1
Repetition
50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Pluri Inc. is listed on the Nasdaq exchange and focusing on US commercial activity, while Alejandro Weinstein holds over 30% ownership. Separately, Abbott acquired CFR Pharmaceuticals for $2.9 billion.

Who's involved

What this event is mainly about
Pluri Inc.Abbott JapanCFR Pharmaceuticals

Keep exploring

The entities involved

  • Pluri Inc.

    Israeli company engaged in the development of human placental adherent stromal cells for commercial use

    Nothing else this week.

  • Abbott Japan

    Nothing else this week.

Coverage

Newest first; wire copies grouped